AKES.OB Insider Trading Activity and SEC Form 4 Filings
AKES.OB insider trading summary
No open-market insider purchases or sales of Akesis Pharmaceuticals, Inc. (AKES.OB) have been reported on SEC Form 4 in the past 12 months.
Latest AKES.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 23, 2008 | Stuart A Fine | Insider | Buy | $2K (5,000 @ $0.49) |
| Aug 1, 2008 | Stuart A Fine | Insider | Buy | $2K (2,500 @ $0.80) |
| Aug 1, 2008 | Stuart A Fine | Insider | Buy | $16K (19,000 @ $0.85) |
| Aug 1, 2008 | Stuart A Fine | Insider | Buy | $39K (42,101 @ $0.93) |
| Jul 28, 2008 | Stuart A Fine | Insider | Buy | $105K (110,050 @ $0.95) |
| Jul 24, 2008 | Stuart A Fine | Insider | Buy | $2K (2,500 @ $0.80) |
| Jul 24, 2008 | Stuart A Fine | Insider | Buy | $11K (11,250 @ $0.94) |
| Jul 24, 2008 | Stuart A Fine | Insider | Buy | $8K (10,000 @ $0.78) |
| Mar 25, 2008 | Avalon Ventures VII L P | 10% Owner | Buy | $2.0M (2,352,942 @ $0.85) |
| Mar 25, 2008 | Kevin J Kinsella | Director | Buy | $2.0M (2,352,942 @ $0.85) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.